National database reveals that cumulative incidence of autism spectrum disorders is increasing

NewsGuard 100/100 Score

Analysis using a national medical database revealed that the cumulative incidence of autism spectrum disorders (ASD) in children born in 2009-2014 was 2.75% by the age of five.

A research group led by Associate Professor Daimei Sasayama and Professor Hideo Honda of the Department of Child and Adolescent Development Psychiatry, Shinshu University School of Medicine, used a national medical database to analyze autism spectrum disorders in Japan. It was reported that the cumulative incidence showed an increasing trend for each year of birth, and that there were regional differences.

This cumulative incidence of ASD is the highest in the world based on medical diagnosis, suggesting high diagnostic sensitivity in Japan. The proportion of people diagnosed with autism spectrum disorders has increased globally over the last 20 years, with a 2014 US survey reporting a prevalence of 1.68% in 8-year-olds.

In addition, a regional cohort study of children's mental development and psychiatry at Shinshu University School of Medicine reported that 3.1% of children had been diagnosed with autism spectrum disorders by school age. Improving screening accuracy is one of the main reasons why more and more people are being diagnosed with autism spectrum disorders.

In order to investigate the actual condition of diagnosis of autism spectrum disorder in Japan, the group investigated the cumulative incidence of autism spectrum disorder nationwide and the cumulative incidence by prefecture using National Database (NDB), which aggregates medical data from all over the country.

For children born in 2009-2016 and diagnosed with autism spectrum disorder in 2009-2019, information on gender, year and age at the time of diagnosis, and the prefecture where the diagnosis was made were extracted from NDB. Cumulative incidence was calculated by dividing the number of diagnoses by the number of births each year.

Of the children born in 2009-2016, 313,353 (236,386 boys, 76,967 girls) were diagnosed with autism spectrum disorder in 2009-2019. The lifetime cumulative incidence of autism spectrum disorders at age 5 in children born between 2009 and 2014 was 2.75%. The cumulative incidence tended to increase with each year of birth. By prefecture, the cumulative lifetime incidence of autism spectrum disorders at age 5 ranged from 0.9-7.9% (median 2.4%).

This study published in the journal JAMA Network Open reported that the cumulative incidence of autism spectrum disorders in Japan is high worldwide. It is thought that the nationwide increasing trend is influenced by the recent increase in awareness of autism spectrum disorders.

On the other hand, since there are large regional differences in the incidence rate, it is possible that factors such as differences in access to medical care and support also affect the incidence rate. The results of this study show that there is an increasing need to build a support system for autism spectrum disorders.

Accurately capturing changes in the frequency of autism spectrum disorders is important both for the realization of an effective support system and for studying the risk factors and etiology of autism spectrum disorders. The research group will continue to investigate trends in the incidence of autism spectrum disorders in Japan and around the world.

Source:
Journal reference:

Sasayama, D., et al. (2021) Trends in Autism Spectrum Disorder Diagnoses in Japan, 2009 to 2019. JAMA Network Open. doi.org/10.1001/jamanetworkopen.2021.9234.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GTF2I gene's role in Williams syndrome and autism unraveled